232 related articles for article (PubMed ID: 16171802)
1. The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil.
Barton ME; Eberle EL; Shannon HE
Eur J Pharmacol; 2005 Oct; 521(1-3):79-85. PubMed ID: 16171802
[TBL] [Abstract][Full Text] [Related]
2. Effects of intrathecal injection of T-type calcium channel blockers in the rat formalin test.
Cheng JK; Lin CS; Chen CC; Yang JR; Chiou LC
Behav Pharmacol; 2007 Feb; 18(1):1-8. PubMed ID: 17218792
[TBL] [Abstract][Full Text] [Related]
3. T-current related effects of antiepileptic drugs and a Ca2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy.
Broicher T; Seidenbecher T; Meuth P; Munsch T; Meuth SG; Kanyshkova T; Pape HC; Budde T
Neuropharmacology; 2007 Sep; 53(3):431-46. PubMed ID: 17675191
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats.
Shannon HE; Eberle EL; Peters SC
Neuropharmacology; 2005 Jun; 48(7):1012-20. PubMed ID: 15857628
[TBL] [Abstract][Full Text] [Related]
5. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
Wen XJ; Xu SY; Chen ZX; Yang CX; Liang H; Li H
Pharmacology; 2010; 85(5):295-300. PubMed ID: 20453553
[TBL] [Abstract][Full Text] [Related]
6. Influence of T-type Ca2+ (mibefradil) and Cl- (indanyloxyacetic acid 94) channel antagonists on alpha1-adrenoceptor mediated contractions in rat aorta.
Duggan JA; Tabrizchi R
Can J Physiol Pharmacol; 2000 Sep; 78(9):714-20. PubMed ID: 11007534
[TBL] [Abstract][Full Text] [Related]
7. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy.
Flatters SJ; Bennett GJ
Pain; 2004 May; 109(1-2):150-61. PubMed ID: 15082137
[TBL] [Abstract][Full Text] [Related]
8. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.
Maeda Y; Aoki Y; Sekiguchi F; Matsunami M; Takahashi T; Nishikawa H; Kawabata A
Pain; 2009 Mar; 142(1-2):127-32. PubMed ID: 19167819
[TBL] [Abstract][Full Text] [Related]
9. Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect.
Palazzo E; Rimoli MG; De Chiaro M; Guida F; Melisi D; Curcio A; de Novellis V; Marabese I; Rossi F; Abignente E; Maione S
Neuropharmacology; 2010 Mar; 58(3):660-7. PubMed ID: 19944111
[TBL] [Abstract][Full Text] [Related]
10. Effects of T-type calcium channel blockers on a parkinsonian tremor model in rats.
Miwa H; Koh J; Kajimoto Y; Kondo T
Pharmacol Biochem Behav; 2011 Feb; 97(4):656-9. PubMed ID: 21112351
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2.
Moosmang S; Haider N; Brüderl B; Welling A; Hofmann F
Circ Res; 2006 Jan; 98(1):105-10. PubMed ID: 16306443
[TBL] [Abstract][Full Text] [Related]
12. Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats.
Todorovic SM; Rastogi AJ; Jevtovic-Todorovic V
Br J Pharmacol; 2003 Sep; 140(2):255-60. PubMed ID: 12970103
[TBL] [Abstract][Full Text] [Related]
13. Chronic intrathecal infusion of mibefradil, ethosuximide and nickel attenuates nerve ligation-induced pain in rats.
Chen YL; Tsaur ML; Wang SW; Wang TY; Hung YC; Lin CS; Chang YF; Wang YC; Shiue SJ; Cheng JK
Br J Anaesth; 2015 Jul; 115(1):105-11. PubMed ID: 26089446
[TBL] [Abstract][Full Text] [Related]
14. Reversal of experimental neuropathic pain by T-type calcium channel blockers.
Dogrul A; Gardell LR; Ossipov MH; Tulunay FC; Lai J; Porreca F
Pain; 2003 Sep; 105(1-2):159-68. PubMed ID: 14499432
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety.
Munro G; Erichsen HK; Mirza NR
Neuropharmacology; 2007 Oct; 53(5):609-18. PubMed ID: 17714743
[TBL] [Abstract][Full Text] [Related]
16. Nefopam and ketoprofen synergy in rodent models of antinociception.
Girard P; Verniers D; Coppé MC; Pansart Y; Gillardin JM
Eur J Pharmacol; 2008 Apr; 584(2-3):263-71. PubMed ID: 18316069
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide as a novel mediator for pancreatic pain in rodents.
Nishimura S; Fukushima O; Ishikura H; Takahashi T; Matsunami M; Tsujiuchi T; Sekiguchi F; Naruse M; Kamanaka Y; Kawabata A
Gut; 2009 Jun; 58(6):762-70. PubMed ID: 19201768
[TBL] [Abstract][Full Text] [Related]
18. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
19. Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker.
Todorovic SM; Meyenburg A; Jevtovic-Todorovic V
Brain Res; 2002 Oct; 951(2):336-40. PubMed ID: 12270514
[TBL] [Abstract][Full Text] [Related]
20. Mibefradil block of cloned T-type calcium channels.
Martin RL; Lee JH; Cribbs LL; Perez-Reyes E; Hanck DA
J Pharmacol Exp Ther; 2000 Oct; 295(1):302-8. PubMed ID: 10991994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
